Results
10
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
10 companies
Abbott India
Market Cap: ₹723.7b
Operates as a pharmaceutical company in India.
500488
₹34,056.60
7D
-1.0%
1Y
22.0%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹528.1b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,117.30
7D
-2.2%
1Y
19.0%
AstraZeneca Pharma India
Market Cap: ₹228.2b
A biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally.
506820
₹9,128.50
7D
-0.6%
1Y
46.2%
Indegene
Market Cap: ₹134.8b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹561.45
7D
-0.4%
1Y
-1.3%
RPG Life Sciences
Market Cap: ₹42.9b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,596.80
7D
4.2%
1Y
40.5%
Novartis India
Market Cap: ₹26.3b
Novartis India Limited is involved in the pharmaceutical business in India.
500672
₹1,066.10
7D
-0.4%
1Y
-9.0%
Jagsonpal Pharmaceuticals
Market Cap: ₹16.6b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹249.04
7D
-1.6%
1Y
81.5%
Alpa Laboratories
Market Cap: ₹2.2b
Engages in the manufacture and sale of pharmaceutical finished dosage forms in India.
ALPA
₹103.45
7D
0.5%
1Y
17.1%
Par Drugs and Chemicals
Market Cap: ₹1.4b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹111.51
7D
17.7%
1Y
-53.4%
Amwill Health Care
Market Cap: ₹1.4b
A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.
544353
₹68.35
7D
2.5%
1Y
n/a